The Cooper Companies, Inc. (LON:0I3I)
London flag London · Delayed Price · Currency is GBP · Price in USD
81.54
-0.96 (-1.16%)
Feb 12, 2026, 4:58 PM GMT

The Cooper Companies Revenue

In the fiscal year ending October 31, 2025, The Cooper Companies had annual revenue of $4.09B USD with 5.06% growth. The Cooper Companies had revenue of $1.07B in the quarter ending October 31, 2025, with 4.59% growth.

Revenue
$4.09B
Revenue Growth
+5.06%
P/S Ratio
3.83
Revenue / Employee
$272.83K
Employees
15,000
Market Cap
11.93B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Oct 31, 20254.09B197.00M5.06%
Oct 31, 20243.90B302.20M8.41%
Oct 31, 20233.59B284.80M8.61%
Oct 31, 20223.31B385.90M13.20%
Oct 31, 20212.92B491.60M20.22%
Oct 31, 20202.43B-222.50M-8.39%
Oct 31, 20192.65B120.60M4.76%
Oct 31, 20182.53B393.80M18.41%
Oct 31, 20172.14B172.20M8.76%
Oct 31, 20161.97B169.70M9.44%
Oct 31, 20151.80B79.32M4.62%
Oct 31, 20141.72B130.05M8.19%
Oct 31, 20131.59B142.59M9.87%
Oct 31, 20121.45B114.30M8.59%
Oct 31, 20111.33B172.32M14.87%
Oct 31, 20101.16B78.10M7.23%
Oct 31, 20091.08B33.05M3.16%
Oct 31, 20081.05B102.14M10.81%
Oct 31, 2007945.24M86.28M10.04%
Oct 31, 2006858.96M52.34M6.49%
Oct 31, 2005806.62M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca43.24B
GSK plc32.67B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
Convatec Group1.72B
CVS Group673.20M
Genus672.80M
Revenue Rankings